monetisation

Digital

Pharmaceutical companies are eagerly pursuing GenAI products and use cases to generate value within their organisations.

News

Skylark Bio has dosed the first patient in a phase 1/2 trial of SKY-GJB2, a gene therapy for the most common form of genetic deafness in children.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.